UK Company and Merck Team Up to Develop Vaccines Based on the Microbiome
Merck will pay the microbiome company 4D Pharma up to €316.5M to develop vaccines based…
October 8, 2019 - 2 minutes
Microbiome: An Emerging Field with Growing Investments
The potential of the microbiome to be used for the development of promising therapeutics and diagnostic approaches has spurred a hype around this emerging field. Over the last decade, researchers have found correlations between the human microbiome and a number of diseases, including inflammatory bowel disease, diabetes, autoimmune diseases, cancer, depression, and many more. As the number of clinical trials grows, investor interest is increasing.
Read on to find out more about the flourishing microbiome field and how it shows promise for the treatment of a large variety of diseases.
Show More
Editor's Picks for Microbiome
- UK Startup Surfs Investment Wave in Microbiome with €18M Series A
- Microbiome Medicines Could Power Up CAR-T Cell Therapies
- Investing in the Microbiome in the Age of Covid-19 and Beyond
- The Missing Piece in the Microbiome Field
- No Guts, No Glory: How Microbiome Research is Changing Medicine
Beyond the Gut: An Atlas of the Human Microbiome
This report discusses the role of the gut and blood microbiomes in different diseases and how they can be used for biomarker discovery and for the development of therapeutics.
Go to ReportLatest Microbiome Articles
Microbiome Food Supplement Improves Metabolic Syndrome in Overweight People
A food supplement made from bacteria, developed by a Belgian research group, has improved symptoms…
July 2, 2019 - 3 minutes
Will US Fecal Transplant Death Impact European Biotech?
The death of a US patient from complications after a fecal transplant last week could…
June 21, 2019 - 2 minutes
Highlights from European Biotech at ASCO 2019
European biotech companies gathered in Chicago, USA, to share the latest advances in cancer research…
June 5, 2019 - 5 minutes
Microbiome Companies Unite to Push for EU Regulation Reform
European microbiome biotechs have launched a collaboration to streamline the EU’s regulatory pathways for microbiome-based…
May 22, 2019 - 2 minutes
The Missing Piece in the Microbiome Field
Over the last decade, the biotech industry has built a lot of hype around the…
May 15, 2019 - 7 minutes
2019 Will Be a “Year of Realism” for Biotech Investments
Biotech investors regularly jump on new crazes, including the microbiome and CRISPR-Cas9 gene editing. At…
May 6, 2019 - 6 minutes
This Biotech Fertilizes Crops with Little Microbe Capsules
We’re zooming over to France this week. The biotech Kapsera makes capsules of microbes that…
April 19, 2019 - 3 minutes
Joint Venture First to Offer Seamless Manufacturing of Microbiome Therapies
Lonza, a Swiss pharma supplier, and Chr. Hansen, a Danish supplier of bacterial products, are…
April 3, 2019 - 2 minutes
Danish Biotech to Develop CRISPR-Based Microbiome Treatments
SNIPR Biome has raised €43M in Series A funds to develop treatments that precisely target…
March 11, 2019 - 2 minutes
Seventure Continues Microbiome Investment Success with Second Fund
After the success of the world’s first fund dedicated to companies in nutrition, digital health,…
March 5, 2019 - 3 minutes
Microbiome Biotech Will Use Series B to Bring Treatments to Clinic
The Israeli biotech BiomX has raised €28M ($32M) to advance its treatments for acne and…
February 21, 2019 - 2 minutes
